Health economic impact of liquid biopsies in cancer management-Reference-Cited by-同舟云学术

Health economic impact of liquid biopsies in cancer management

Published:2018-08-07 Issue:6 Volume:18 Page:593-599
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

IJzerman Maarten J.¹²³^ORCID,Berghuis A.M. Sofie¹^ORCID,de Bono Johann S.⁴,Terstappen Leon W.M.M.⁵^ORCID

Affiliation:

1. Department of Health Technology and Services Research, University of Twente, Enschede, the Netherlands

2. University of Melbourne, Faculty of Medicine, Dentistry and Health Sciences, Victorian Comprehensive Cancer Centre and Centre for Cancer Research, Melbourne, Australia

3. Luxembourg Institute of Health, Dept. Health Economics and Evidence Synthesis, Luxembourg

4. Royal Marsden Hospital, Institute for Cancer Research, Clinical studies department, Surrey, UK

5. Department of Medical Cell Biophysics, University of Twente, Enschede, the Netherlands

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2018.1505505

Reference67 articles.

1. Economic burden of cancer across the European Union: a population-based cost analysis

2. Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context

3. Responsible pricing in value-based assessment of cancer drugs: real-world data are an inevitable addition to select meaningful new cancer treatments

4. Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received

5. Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High HER2 Intratumoral Heterogeneity Is a Predictive Factor for Poor Prognosis in Early-Stage and Locally Advanced HER2-Positive Breast Cancer;Cancers;2024-03-05

2. Re‐re‐biopsy? How much tumor is enough in the era of precision oncology?;Asia-Pacific Journal of Clinical Oncology;2023-10-02

3. The difficult “childhood era” of the liquid biopsy as a diagnostic method in head and neck cancer patients;Otolaryngologia Polska;2023-09-29

4. Point‐of‐Care Testing for the Detection of MicroRNAs: Towards Liquid Biopsy on a Chip;Angewandte Chemie;2023-09-19

5. Point‐of‐Care Testing for the Detection of MicroRNAs: Towards Liquid Biopsy on a Chip;Angewandte Chemie International Edition;2023-09-19